CS Paper Radar

Observation-Anchored Selective Assimilation for Longitudinal Tumor-State Proxy Forecasting in Post-Treatment Glioma

Yeonjae Jung, Minwoo Shin

cs.LG cs.AI ·submitted 2026-09-11 04:55 UTC · v1
code/data

Abstract

Post-treatment MRI in patients with glioma provides serial observations for updating patient-specific tumor-state proxy estimates, but variable appearances and trajectories complicate forecasting. We formulate forecasting as an observation-aware digital-twin update in which an intermediate observation anchors the patient-specific state. Among 203 patients and 594 follow-up time points, a predefined no-new-treatment criterion retained 120 of 236 candidate triplets, split into 81/24/15 training/validation/test triplets at the patient level. Each time point was represented by a continuous voxel-wise tumor-state proxy map in [0,1] derived from MRI lesion labels. A SegMamba-based single-step forecaster predicted update proposals from multimodal source-state tensors. Observation-Anchored Selective Assimilation (OASA) retained the observed intermediate proxy as the state anchor and selectively applied updates through a validation-selected tiered case-level rule and voxel-wise soft gate. We compared initial-scan forecasting, rollout without assimilation, latest-observation persistence, direct prediction, OASA, OASA + calibration, and morphological dilation. Checkpoints, OASA rules, and calibration thresholds were selected using validation data only. Across three seeds on 15 held-out test triplets, OASA maintained Dice at $τ$ = 0.2 comparable to persistence (0.6071 $\pm$ 0.0025 vs. 0.6070) while yielding numerically higher Dice at $τ$ = 0.5 (0.4269 $\pm$ 0.0079 vs. 0.3981), with a small RMSE increase. Calibration increased Dice at $τ$ = 0.2 to 0.6178 $\pm$ 0.0025, increased false-positive (FP) support (11,836$\rightarrow$18,663), and reduced false-negative (FN) support (22,107$\rightarrow$17,536). This reflects near-threshold support calibration rather than improved biological predictive capability. Code is publicly available at https://github.com/jsudg436/longitudinal-proxy-forecasting.

Closest papers

Nearest neighbours by meaning across the whole index.

STRIDE: Spatial-Temporal Representation for Interval-conditioned Disease Evolution in Longitudinal Glioblastoma MRI

eess.IV cs.AIcs.CV ·2026-10-02 ·Wenhao Guo, Changchang Yin, Pierre Giglio, Weidan Cao, Ping Zhang +1 more
similarity 0.70
Abstract · 37 pages, 11 figures

Glioblastoma (GBM), an aggressive primary brain tumor, is routinely monitored with longitudinal MRI after treatment. Distinguishing stable disease (SD), pseudoprogression (PsP), and true progression (TP) remains challenging because these states can show overlapping MRI appearances despite different temporal trajectories. Existing longitudinal methods still face challenges in modeling scan-specific spatial variability, variable follow-up intervals, and complementary information from the observed follow-up state and its longitudinal change. We propose STRIDE, a framework for spatial-temporal representation of interval-conditioned disease evolution that takes paired post-treatment MRI scans and their inter-scan interval as input and predicts SD, PsP, or TP. The lesion-prior-guided spatial representation combines SoftGate and an Adaptive-window Hierarchical Transformer (AWHT) to emphasize lesion-related regions while preserving surrounding context. The time-conditioned latent transition uses pair-level context and the actual inter-scan interval to estimate interval-dependent representation changes between visits. The observed--transition fusion integrates the transition-estimated follow-up representation with the directly observed follow-up representation to jointly characterize the follow-up state and its longitudinal change. BraTS2024 is used to develop and evaluate the lesion-prior generator, while longitudinal pretraining on LUMIERE supports transfer before downstream adaptation to Burdenko. On the Burdenko three-class task, STRIDE achieves a macro ROC--AUC of 0.816 and a macro F1-score of 0.796. These results support its potential for more reliable longitudinal post-treatment GBM state assessment.

0.16

Patient, Place, Prior (P$^3$): What Counts as Personalization in Medical World Models?

cs.LG cs.AI ·2026-10-06 ·Xingrui Gu, Hanxue Gu, Yuxiang Zhang, Yang Yang
similarity 0.67
Abstract · 12 pages, 1 figure, 2 tables

Longitudinal models forecast how a patient's imaging state evolves, but accuracy does not show whether the patient's observed trajectory drives the prediction. A population-average forecast may be useful but cannot establish a patient-specific world-model claim. We introduce Patient, Place, Prior (P$^3$), an audit asking whether a forecast benefits from the patient's longitudinal imaging history (Patient), benefits from patient-matched externally supplied spatial support (Place), and gains predictive value beyond a population-average prediction under matched support and context (Prior). We also propose Cancer JEPA, a one-step model that forecasts frozen representations of future breast dynamic contrast-enhanced MRI examinations during neoadjuvant therapy. It adds a lesion-constrained neural correction, trained with an occlusion-based latent objective, to a patient-conditioned low-complexity reduced-rank regression baseline. This factorization permits a post-hoc P$^3$ audit of the frozen model. In a validation cohort previously used in development, forecast error is lower when the neural correction receives the patient's history rather than another patient's and patient-matched lesion occupancy maps rather than substituted maps. However, the descriptive 95% interval comparing the correction computed from patient history with the population-average neural correction includes zero. P$^3$ thus separates input use from evidence of patient-specific predictive value beyond a population-level pattern.

0.20

GliomaINK: A Tumor and Anatomy Conditioned Flow Matching Framework for 3D MRI Sequence Synthesis in Glioma Patients

eess.IV cs.CVq-bio.TO ·2026-10-16 ·Moinak Bhattacharya, Annie Singh, Mohammad Chaudhry, Prateek Prasanna, Gagandeep Singh
similarity 0.65
Abstract

Background: Incomplete multiparametric MR examinations limit glioma characterization and downstream AI tools. Generative models can synthesize missing MRI sequences, but anatomical structure and clinically relevant tumor features are challenging to preserve. We propose GliomaINK, an anatomy-guided conditional flow matching framework for cross-sequence 3D brain MRI synthesis. Methods: A 3D SwinUNETR predicted the conditional velocity field while an auxiliary topology-preserving loss encouraged structural consistency. The model was trained on 1,083 patients from the BraTS-AG dataset and independently tested on an in-house clinical cohort. Downstream tasks include image quality, tumor segmentation, IDH1 mutation-status prediction, and overall survival prediction. Two radiologists independently evaluated the anatomical fidelity, pathological representation, and overall image quality of the synthesized images. Results: GliomaINK exhibited the highest PSNR across all six MRI translation directions in both evaluation cohorts. In the BraTS-AG test set, the PSNR reached $25.64\pm0.55$ dB for the T2W-to-T1C synthesis, compared with $13.78\pm0.32$ dB for Pix2Pix and $18.90\pm0.53$ dB for SPADE. For downstream tumor segmentation, the method showed strong performance across tumor subregions with Dice scores reaching $0.928\pm0.014$ for edema, and $0.885\pm0.040$ for enhancing tumor. For the IDH1 mutation-status prediction, GliomaINK achieved the highest AUROC score in four of the six sequence configurations, reaching $0.827\pm0.088$. Conclusion: Anatomy-guided conditional flow matching enables high-fidelity cross-sequence glioma MRI synthesis demonstrating potential for preservation of clinically relevant information in synthesized MRI and improving downstream tasks.

0.18

Multimodal-Conditioned Latent Diffusion Models for Spatiotemporal Brain MRI Forecasting

cs.CV cs.AI ·2026-10-18 ·Antonio Scardace, Silvia Ingala, Sebastiano Battiato, Daniele Ravì
publishedcode/data similarity 0.63
Abstract · Accepted to WACV 2027

Spatiotemporal forecasting of 3D anatomical changes is a critical generative vision challenge for modeling Alzheimer's Disease (AD) progression. While brain MRI forecasting from single-modality data has advanced, other key complementary multimodal biomarkers remain underutilized. In this work, we propose the Multimodal-Conditioned Latent Diffusion Model (MC-LDM), a novel framework for patient-specific brain MRI synthesis. MC-LDM leverages multimodal biomarkers---MRI, tau-PET, Clinical Dementia Rating (CDR), and APOE4---during training, but relies only on baseline MRI, APOE4, and patient metadata at inference, reflecting realistic clinical availability. Our contributions are threefold: (1) a Latent Diffusion Model (LDM) fine-tuned via Low-Rank Adaptation (LoRA) for data-efficient learning; (2) a multimodal conditioning that integrates molecular and clinical signals to model heterogeneous disease trajectories; and (3) auxiliary predictors estimating unobserved multimodal biomarkers from MRI features and patient covariates to condition the diffusion model, removing the need for these assessments at inference. Trained on 1,355 visits from 852 subjects in the Alzheimer's Disease Neuroimaging Initiative (ADNI), MC-LDM reduces average regional volumetric MAE by 18% over the second-best baseline on an independent test set of 664 visits. To our knowledge, MC-LDM represents the first diffusion-based framework to leverage multimodal priors for MRI forecasting. This conceptual advancement enables patient-specific trajectory generation that captures aspects of AD heterogeneity not observable from structural anatomy alone, bridging the gap between rich multimodal supervision and the strict constraints of routine clinical deployment. Code is available at: https://github.com/antonioscardace/MC-LDM.

0.43

Progressive multi-scale tumor-state memory for incomplete multimodal brain tumor segmentation

eess.IV cs.CV ·2026-10-19 ·Milad Rostamian, Mohammadreza Mohammadi, Mohsen Soryani
similarity 0.63
Abstract

Brain tumor segmentation uses complementary magnetic resonance imaging (MRI) sequences, but some sequences may be unavailable in practice. Their absence changes the information available for segmenting different tumor regions. Fusion methods can support different input subsets. However, fusion at several scales does not by itself specify how tumor evidence is retained and updated to guide fusion at later stages. We propose a progressive multi-scale tumor-state memory network (PMTM) for segmentation from any non-empty subset of T1ce, T1, FLAIR, and T2. PMTM maintains a compact state for the current subject across the encoder stages. At each stage, we use assignment maps to pool spatial features into ordered evidence vectors for each available modality. We average these vectors across the available modalities, and a learned gate combines this evidence with the previous state. The up- dated state guides residual fusion at that stage and is used in the state update at the next stage. A modality-token mixer also models interactions among the available modalities at each stage. We apply semantic supervision to the assignment maps at all four stages. We evaluate PMTM on BraTS2018, BraTS2020, and BraTS2023 GLI across all 15 non-empty modality subsets. Averaged over the three tumor regions and the 15 subsets, PMTM achieves Dice scores of 75.31%, 77.54%, and 80.47% on BraTS2018, BraTS2020, and BraTS2023 GLI, respectively. These scores are higher than those of RobustSeg, RFNet, and mmFormer in our experiments on each dataset. Component ablations and internal state analysis are performed on BraTS2020.

0.06

Intervention-Aware Clinical World Model for Post-Op Outcome Forecasting in Cardiology

cs.LG cs.CV ·2026-08-13 ·Yunsung Chung, Yingshuo Liu, Abboud F. Hassan, Han Feng, Mary M. Maleckar +2 more
published similarity 0.63
Abstract · Medical World Models (MWM) Workshop at MICCAI 2026

Many clinical prediction models treat post-intervention outcomes as a one-step mapping from baseline measurements to a future endpoint. However, recovery after a procedure often unfolds as an irregular trajectory: clinical observations, medication changes, repeat interventions, and physiological measurements are recorded asynchronously and can change risk assessment over time. We propose an intervention-aware clinical world model that represents each patient with a structured latent state and evolves it through time-ordered post-intervention events. The model first encodes baseline imaging into a 3D spatial latent state. It then updates this state using procedural context, static covariates, elapsed time, and peri-event physiological embeddings. Follow-up imaging provides training-only supervision through a latent forecasting objective. We apply the framework to atrial fibrillation ablation. During the 90-day recovery window, irregular post-procedure records provide clinically meaningful evidence for long-term recurrence risk. In repeated internal cross-validation on DECAAF-II, our model achieves AUROC 0.756 and AUPRC 0.777 for recurrence prediction. It also achieves a scar-extent MAE of 2.971 percentage points without requiring follow-up MRI intensities at inference. The learned state supports recurrence-risk queries at different horizons and retrospective input editing of blanking-period records.

0.46

CFB-GBM v2.0: An Augmented Longitudinal Dataset for Multi-Modal Glioblastoma Segmentation, Radiomics, and RANO Progression Tracking

cs.CV ·2026-08-18 ·Alexandre G. Leclercq, Noémie N. Moreau, Hugo Audebert, Andros Nassar, Thomas Cochin +19 more
top venue similarity 0.62
Abstract · 9 pages, 2 figures,

Glioblastoma (GBM) is the most aggressive primary brain tumor in adults, with a median overall survival of 15 months. Longitudinal, multi-modal imaging datasets with comprehensive clinical and treatment data are essential to support the development of reproducible computational methods for treatment response prediction, disease progression modelling, and personalized medicine. We present CFB-GBM v2.0, an extension of our previously released CFB-GBM dataset comprising 264 GBM patients treated according to the standard Stupp protocol. The primary contribution of this release is the completion of Gross Tumour Volume (GTV) delineations across all available timepoints ($t_0$, $t_1$ and $t_2$), increasing the overall GTV completion rate from 35% to 97%. This was achieved using a nnU-Net model pre-trained on BraTS 2021 and fine-tuned on CFB-GBM ground-truth contours, with the generated segmentations validated by five radiation oncologists. From these longitudinal GTV annotations, volumetric RANO 2.0 response category labels were derived for all available temporality pairs ($t_0 \rightarrow t_1$, $t_0 \rightarrow t_2$ and $t_1 \rightarrow t_2$). To further ease dataset usability and reproducibility, brain masks computed with HD-BET and pre-computed radiomic features extracted with PyRadiomics are provided for each patient timepoint and MRI modality. Additionally, the WHO classification guideline (2016 vs. 2021) applicable to each patient's diagnosis is now explicitly documented. CFB-GBM v2.0 is publicly available on The Cancer Imaging Archive (TCIA) at https://www.cancerimagingarchive.net/collection/cfb-gbm .

0.67

CoRe-WM: Conditioned Response-State World Modeling for Longitudinal Treatment-Response Prediction in Breast DCE-MRI

cs.CV ·2026-10-18 ·Lin Zhao, Bowen Chen, Qiaohui Gao, Shaowen Wan, Xiang Li +2 more
similarity 0.62
Abstract

Pathologic complete response (pCR) after neoadjuvant chemotherapy is a key prognostic indicator in aggressive breast cancer, yet existing prediction approaches either rely on pretreatment imaging alone, missing the patient's evolving response, or optimize multi-visit classifiers under direct outcome supervision, coupling representation learning with the clinical endpoint. We formulate longitudinal pCR prediction as a world-modeling problem and propose Conditioned Response-state World Modeling (CoRe-WM), which learns a latent state-transition model that predicts the next imaging state from the observed sequence. The transition function is conditioned on patient clinical profile and assigned therapy through additive shift and feature-wise modulation, enabling patient- and treatment-specific dynamics. A Factorized Response State pathway further decouples treatment-response dynamics from imaging appearance by encoding the structural prior that response manifests primarily in lesion morphology. After pretraining, all parameters are frozen and a linear readout predicts pCR at each clinical decision point. We evaluate CoRe-WM on I-SPY2 under five-fold cross-validation and assess cross-cohort transfer on I-SPY1. CoRe-WM achieves the highest discrimination among all evaluated methods at every prospective decision point, and demonstrates robust cross-cohort transfer. Ablation studies identify patient-profile conditioning and the factorized response pathway as the principal contributors. These results establish world-model-based representation learning as a promising framework for outcome prediction in oncology and beyond.

0.20